ABIONYX Pharma SA (EPA:ABNX)
France
· Delayed Price · Currency is EUR 1.296
+0.014 (1.09%)
May 30, 2025, 5:19 PM CET
ABIONYX Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.24 | 4.1 | 4.05 | 7.94 | 9.15 | Upgrade
|
| Cash & Short-Term Investments | 3.24 | 4.1 | 4.05 | 7.94 | 9.15 | Upgrade
|
| Cash Growth | -21.17% | 1.43% | -49.01% | -13.32% | 9.88% | Upgrade
|
| Accounts Receivable | 0.99 | 0.91 | 1.3 | 1.33 | - | Upgrade
|
| Other Receivables | 1.3 | 1.58 | 1.76 | 3.29 | 0.84 | Upgrade
|
| Receivables | 2.3 | 2.5 | 3.05 | 4.62 | 0.84 | Upgrade
|
| Inventory | 0.21 | 0.22 | 0.15 | 0.18 | - | Upgrade
|
| Prepaid Expenses | 0.12 | 0.07 | 0.33 | 0.28 | 0.04 | Upgrade
|
| Total Current Assets | 5.86 | 6.89 | 7.57 | 13.01 | 10.03 | Upgrade
|
| Property, Plant & Equipment | 1.98 | 2.22 | 2.56 | 3.07 | 0.12 | Upgrade
|
| Long-Term Investments | 0.08 | 0.08 | 0.08 | 0.08 | - | Upgrade
|
| Goodwill | 5.38 | 5.38 | 5.38 | 5.38 | - | Upgrade
|
| Other Intangible Assets | 0.08 | 0.08 | 0.08 | 0.08 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0.11 | 0.14 | 0.12 | 0.19 | 0.1 | Upgrade
|
| Total Assets | 13.54 | 14.83 | 15.82 | 21.83 | 10.29 | Upgrade
|
| Accounts Payable | 1.63 | 1.44 | 1.85 | 2.71 | 2.41 | Upgrade
|
| Accrued Expenses | 0.93 | 1.03 | 1.03 | 1.51 | 0.23 | Upgrade
|
| Short-Term Debt | - | 0 | 0 | 0.17 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.5 | 0.5 | 0.49 | 0.49 | - | Upgrade
|
| Current Portion of Leases | 0.34 | 0.31 | 0.38 | 0.4 | 0.02 | Upgrade
|
| Current Unearned Revenue | 0.29 | 0.59 | 0.38 | 0.43 | 0 | Upgrade
|
| Other Current Liabilities | 0.01 | 0.06 | 0.96 | 1.04 | 0.93 | Upgrade
|
| Total Current Liabilities | 3.71 | 3.93 | 5.09 | 6.75 | 3.6 | Upgrade
|
| Long-Term Debt | 0.61 | 1.1 | 1.42 | 1.65 | - | Upgrade
|
| Long-Term Leases | 1.3 | 1.47 | 1.73 | 2.25 | - | Upgrade
|
| Total Liabilities | 6.03 | 6.91 | 8.65 | 11.16 | 3.66 | Upgrade
|
| Common Stock | 1.75 | 1.62 | 1.42 | 1.4 | 1.23 | Upgrade
|
| Additional Paid-In Capital | 8.61 | 12.57 | 8.6 | 179.21 | 170.32 | Upgrade
|
| Retained Earnings | -4.38 | -3.52 | -4.21 | -5.82 | -1.89 | Upgrade
|
| Treasury Stock | -0.25 | -0.19 | - | - | - | Upgrade
|
| Comprehensive Income & Other | 1.8 | -2.56 | 1.36 | -164.11 | -163.04 | Upgrade
|
| Shareholders' Equity | 7.52 | 7.92 | 7.17 | 10.68 | 6.63 | Upgrade
|
| Total Liabilities & Equity | 13.54 | 14.83 | 15.82 | 21.83 | 10.29 | Upgrade
|
| Total Debt | 2.76 | 3.39 | 4.01 | 4.96 | 0.02 | Upgrade
|
| Net Cash (Debt) | 0.48 | 0.71 | 0.03 | 2.98 | 9.13 | Upgrade
|
| Net Cash Growth | -33.05% | 2063.64% | -98.89% | -67.39% | 27.73% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.02 | 0.00 | 0.12 | 0.39 | Upgrade
|
| Filing Date Shares Outstanding | 34.68 | 32.21 | 28.1 | 27.7 | 24.4 | Upgrade
|
| Total Common Shares Outstanding | 34.68 | 32.21 | 28.1 | 27.7 | 24.4 | Upgrade
|
| Working Capital | 2.15 | 2.96 | 2.48 | 6.26 | 6.44 | Upgrade
|
| Book Value Per Share | 0.22 | 0.25 | 0.26 | 0.39 | 0.27 | Upgrade
|
| Tangible Book Value | 2.06 | 2.47 | 1.72 | 5.22 | 6.58 | Upgrade
|
| Tangible Book Value Per Share | 0.06 | 0.08 | 0.06 | 0.19 | 0.27 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.